Stat5 tetramer formation is associated with leukemogenesis-Reference-Cited by-同舟云学术

Stat5 tetramer formation is associated with leukemogenesis

Published:2005-01 Issue:1 Volume:7 Page:87-99
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Moriggl Richard,Sexl Veronika,Kenner Lukas,Duntsch Christopher,Stangl Katharina,Gingras Sebastien,Hoffmeyer Angelika,Bauer Anton,Piekorz Roland,Wang Demin,Bunting Kevin D.,Wagner Erwin F.,Sonneck Karoline,Valent Peter,Ihle James N.,Beug Hartmut

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference45 articles.

1. Signal transduction and the control of gene expression;Brivanlou;Science,2002

2. Stat proteins and oncogenesis;Bromberg;J. Clin. Invest.,2002

3. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention;Buettner;Clin. Cancer Res.,2002

4. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5;Bunting;Blood,2002

5. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation;Cui;Mol. Cell. Biol.,2004

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial and transcriptional response of Acropora valida and Turbinaria peltata to Vibrio coralliilyticus challenge: insights into corals disease resistance;BMC Microbiology;2024-08-02

2. Age‐associated myeloid malignancies – the role of STAT3 and STAT5 in myelodysplastic syndrome and acute myeloid leukemia;FEBS Letters;2024-07-24

3. C/EBPβ-induced lymphoid-to-myeloid transdifferentiation emulates granulocyte-monocyte progenitor biology;Stem Cell Reports;2024-01

4. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-18

5. Small molecule STAT3/5 inhibitors exhibit therapeutic potential in acute myeloid leukemia and extra-nodal natural killer/T cell lymphoma;2023-10-16